claim: rapid clinical recovery of critical covid-19 icu patient with respiratory failure treated with rlf-2 drug
evidence_1: four days earlier, relief and neurorx said that rlf-100 showed rapid recovery from respiratory failure in the most critically ill patients with covid-19those on ventilators and ecmo (extracorporeal membrane oxygenation)who were treated under fda emergency use ind authorization.", "august 2, 2020 \\- critically ill covid-19 patients recovered rapidly from respiratory failure after three days of treatment with rlf-100, a therapy granted fast-track designation in the united states, two drug companies said sunday."
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  )